FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Analogue topics
Carbon Dioxide
Amino Acid
Radio Signal
Inorganic Compounds
Hydrogen Production From Water
Electrolysis
Semiconductor
High Energy
Semiconductor Material
Transmitter
Synchronization
Concurrent
Surfactant
Hyperglycemia
Pharmaceutically Acceptable Salt

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Analogue patents



      
           
This page is updated frequently with new Analogue-related patent applications. Subscribe to the Analogue RSS feed to automatically get the update: related Analogue RSS feeds. RSS updates for this page: Analogue RSS RSS


Three-phase power supply and system of leds with three-phase power supply

Wladyslaw Wlodarczyk Igloo

Three-phase power supply and system of leds with three-phase power supply

Date/App# patent app List of recent Analogue-related patents
02/26/15
20150057224
 Methods for chronic pain management and treatment using hcg patent thumbnailnew patent Methods for chronic pain management and treatment using hcg
A gonadotropin is administered within a surprisingly effective narrow range for the purpose of treating chronic pain or other central sensitization sequelae. In one aspect, a recipient is provided with at least one of human chorionic gonodotropin (uhcg and/or rhcg), a pharmaceutically active hcg analogue, and a pharmaceutically active metabolite of the hcg or analogue at a dosage selected to provide, or be equivalent to, a human subcutaneous dosage of between 120 iu/day and 170 iu/day of hcg, and more preferably between 140 iu/day and 160 iu/day of hcg.
Neuralight Hd, Llc
02/26/15
20150056165
 Novel cyclosporin analogues for preventing or treating hepatitis c infection patent thumbnailnew patent Novel cyclosporin analogues for preventing or treating hepatitis c infection
The present invention relates to novel cyclosporine analogues having antiviral activity against hcv and useful in the treatment of hcv infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds..
Enanta Pharmaceuticals, Inc.
02/26/15
20150054408
 Three-phase power supply and system of leds with three-phase power supply patent thumbnailnew patent Three-phase power supply and system of leds with three-phase power supply
A three-phase power supply (10), intended especially to supply leds system (20), has a system of a diode bridge rectifier which comprises rectifying diodes (101, 102, 103, 104, 105, 106). The three-phase power supply (10) is additionally equipped with fets and each of the rectifying diodes is bypassed by an fet of a rectifying unit (111, 112, 113, 114, 115, 116), respectively, which is controlled by a control system (40), comprising en anglogue-to-digital converter adc 403, a digital-to-analogue converter (402), a microcontroller (401), which provides a control signal to a gate of the appropriate fet through the input/output (404).
Wladyslaw Wlodarczyk Igloo
02/19/15
20150052640
 Method for enhancing drought tolerance in plants patent thumbnailMethod for enhancing drought tolerance in plants
A method for increasing drought tolerance in a plant or photosynthetic organism is provided, where the tolerance is increased by applying an effective amount of trimethylamine n-oxide (tmao) or trimethylamine n-oxide di-hydrate, or a tmao chemical derivative, or a tmao chemical analogue and thereof to a plant, seed or photosynthetic organism that has been exposed to or to be exposed to water stress conditions. Water stress tolerant plants or photosynthetic organisms produced through the application of trimethylamine n-oxide (tmao) or trimethylamine n-oxide di-hydrate, or a tmao chemical derivative, or a tmao chemical analogue to a plant or photosynthetic organism are also disclosed..
02/19/15
20150051142
 Novel  peroral delivery of insulin and its analogues for therapeutic usage patent thumbnailNovel peroral delivery of insulin and its analogues for therapeutic usage
A method for treating type 1 and type 2 diabetes by administering an oral pharmaceutical formulation which comprises of insulin or its analogues amalgamated with suitable encapsulating agents and pharmaceutical excipients. The encapsulated pharmaceutical oral formulation protects insulin or its analogues from harsh milieu of the gastrointestinal tract and facilitates efficient delivery of insulin at targeted sites with sustained hypoglycemic activity..
Transgene Biotek Ltd
02/19/15
20150051137
 Peptide and uses therefor patent thumbnailPeptide and uses therefor
Provided is a method for treatment and/or prophylaxis of a condition associated with t cell mediated chronic inflammatory disease by administration, to a patient, of a peptide comprising n′-svteqgaelsneer-c′ {seq id no: 1) or an analogue thereof that inhibits t cell migration. Also provided is the peptide or its analogue for use in the methods of treatment: and/or prophylaxis of said condition..
The University Of Birmingham
02/19/15
20150049340
 Optical coherence tomography with an extended dynamic range patent thumbnailOptical coherence tomography with an extended dynamic range
The invention lies in the field of optical metrology and relates to optical coherence tomography (oct). In particular, the invention relates to an apparatus and a method for the depth-dependent adaptation of the dynamic range of an oct system to the profile of the backscattered power to be measured.
Karlsruher Institut FÜr Technologie
02/12/15
20150045451
 Polymeric biomaterials derived from monomers comprising hydroxyacids and phenol compounds and their medical uses patent thumbnailPolymeric biomaterials derived from monomers comprising hydroxyacids and phenol compounds and their medical uses
The present invention provides new classes of phenolic compounds derived from hydroxyacids and tyrosol or tyrosol analogues, useful as monomers for preparation of biocompatible polymers, and the biocompatible polymers prepared from these monomeric hydroxyacid-phenolic compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations.
Rutgers, The State University Of New Jersey
02/12/15
20150045404
 Schweinfurthin analogues patent thumbnailSchweinfurthin analogues
The invention provides a compound of formula (i): wherein r1-r5 have any of the values defined in the specification. The compounds are useful for the treatment of cancer and other diseases..
University Of Iowa Research Foundation
02/12/15
20150045384
 Morphan and morphinan analogues, and methods of use patent thumbnailMorphan and morphinan analogues, and methods of use
The present application relates to analogues of morphan and morphinan, compositions thereof, and methods for treating a disease or condition comprising administering an effective amount of the compounds or compositions to a subject in need thereof.. .
Alkermes Pharma Ireland Limited
02/12/15
20150045281

Glp-1 prodrugs


The invention relates to a glp-1 prodrug of the general formula i: r1-(nhxaa1)-xaa2-(ohis)-(glp-1 peptide) (formula i), wherein glp-1 peptide is glp-1(8-37) (seq id no: 1) or an analogue thereof having a maximum of nine amino acid changes as compared to glp-1(8-37), r1 is lower alkyl, (nhxaa1) is an amino acid, xaa2 is an amino acid, and (ohis) is a radical of imidazole-lactic acid; or a pharmaceutically acceptable salt, amide, or ester of the prodrug. The invention also relates to specific glp-1 parent drugs of the general formula ii: (hohis)-(glp-1 peptide) (formula ii), as well as specific intermediate products.
Novo Nordisk A/s A Corporation
02/12/15
20150044228

Methods to identify compounds useful for the treatment of proliferative and differentiative disorders


The present invention relates to the discovery, identification and characterization of nucleotide sequences that encode novel substrate-targeting subunits of ubiquitin ligases. The invention encompasses nucleotides encoding novel substrate-targeting subunits of ubiquitin ligases: fbp1, fbp2, fbp3, fbp4, fbp5, fbp6, fbp7, fbp8, fbp9, fbp10, fbp11, fbp12, fbp13, fbp14, fbp15, fbp16, fbp17, fbp18, fbp19, fbp20, fbp21, fbp22, fbp23, fbp24, and fbp25, transgenic mice, knock-out mice, host-cell expression systems and proteins encoded by the nucleotides of the novel substrate-targeting subunits.
New York University
02/12/15
20150042326

Method and device for measuring currents or magnetic fields using hall sensors


The present invention relates to a method and a device for measuring currents or magnetic fields using at least one hall sensor, which is operated with spinning current technology. In addition to first sample values for calculating a spinning current measurement value (6), second sample values are formed from the digitally converted sensor signals (1) of the hall sensor in the method.
Fraunhofer-gesellschaft Zur Foerderung Der Angewandten Forschung E.v.
02/05/15
20150038674

Use of glp-2 analogues in pulmonary diseases for therapeutic purpose


The present invention relates to the use of glp-2 analogue in an efficient amount for the production of a drug specific to treat a pulmonary disease which is caused by oxidative stress, inflammation and/or apoptosis in an organism.. .
02/05/15
20150038571

Antiviral composition against flavivirus


The present invention relates to a composition having antiviral activity for prophylaxis or treatment of flavivirus infection or a disease resulting therefrom in humans or animals, characterised in that said composition consisting of baicalein, or analogues, or derivatives thereof. The composition may further comprise a pharmaceutically acceptable carrier.
University Malaya
02/05/15
20150038463

Compositions and methods to treat cardiac diseases


Phosphonate and phosphinate n-methanocarba derivatives of amp including their prodrug analogs are described. Mrs2339, a 2-chloro-amp derivative containing a (n)-methanocarba(bicyclo[3.1.0]hexane) ring system in place of ribose, activates p2x receptors, ligand-gated ion channels.
The United States Of America, As Represented By The Secretary, Department Of Health And Human Ser
02/05/15
20150038414

Organic compounds


A pharmacutical composition for parenteral administration of a somatostatin analogue salt of aspartate, e.g. Mono- or diaspartate, lactate, succinate, e.g.
Novartis Ag
02/05/15
20150037490

Frozen dessert mixes using canola protein products


A canola protein product having a protein content of at least about 60 wt % (n×6.25) d.b., preferably at least about 90 wt %, and consisting predominantly of 2s canola protein and derived from supernatant from a protein micellar mass settling step is used to provide, at least in part, the protein component of a dairy analogue or plant/dairy blend frozen dessert mix.. .
02/05/15
20150036771

Device and communication correction


Embodiments of the present invention provide a device and method for communication correction. The device includes a receiving channel and a correction channel, where the receiving channel includes an analogue radio-frequency front end, a demodulator, a first analogue-to-digital converter, and a first channel correction module that are connected sequentially, and the correction channel includes a frequency converter, a second analogue-to-digital converter, and a digital processor that are connected sequentially, where the analogue radio-frequency front end is further connected to the frequency converter, and the digital processor is connected to the first channel correction module.
Huawei Technologies Co., Ltd.
01/29/15
20150031899

Cucn-mediated one pot production of cinnamonitrile derivatives


The present invention discloses a cheaper and practical protocol for the construction of a wide variety of o-cyanocin-namonitrile and their structural analogues that proceeds with good yields in a single step using cucn as the only reagent.. .
Council Of Scientific & Industrial Research
01/29/15
20150031898

Process for preparation of prostaglandin f2 alpha analogues


A convergent synthesis of the prostaglandin f2α analogues, travoprost and bimatoprost, was developed employing julia-lythgoe olefination of the structurally advanced phenylsulfone with an enantiomerically pure aldehyde ω-chain synthon. The novel convergent strategy allows the synthesis of a whole series of prostaglandin analogues of high purity from a common and structurally advanced prostaglandin intermediate..
Instytut Farmaceutyczny
01/29/15
20150031759

Analogues of (-)picropodophyllin, synthesis and uses thereof


Compounds, compositions, methods of making, and methods of using analogues of (−)-picropodophyllin, as well as a transgenic animal model and its use for identifying anticancer agents.. .
University Of Nebraska - Lincoln
01/29/15
20150031701

Compositions and methods for preventing and treating mucositis and weight loss


Pharmaceutical compositions comprising 5-[2-pyrazinyl]-4-methyl-1,2-3-thione or an analogue, derivative, metabolite, prodrug, solvate or a pharmaceutically acceptable salt thereof; and a pharmaceutical carrier, which promotes association with the outer wall of a subject's digestive tract are described as well as their uses in treating and preventing mucositis and cachexia.. .
St Ip Holding Ag
01/29/15
20150030656

Composition and delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis


A composition comprising a synthetic growth factor analogue comprising a non-growth factor heparin binding region, a linker and a sequence that binds specifically to a cell surface receptor and an osteoconductive material where the synthetic growth factor analogue is attached to and can be released from the osteoconductive material and is an amplifier/co-activator of osteoinduction.. .
Biosurface Engineering Technologies, Inc.
01/29/15
20150030566

Antimicrobial peptide compositions for plants


Compositions containing one or more tyrocidines, tryptocidines, phenycidines and/or gramicidin s, or derivatives and analogues thereof, are described for controlling antimicrobial growth on plants, plant material or plant growth media, and methods for controlling or preventing the growth of microbial pathogens, and in particular fungal pathogens, on plants, plant parts and plant material are described herein. The active agents used to control these pathogens are tyrocidines, tryptocidines, phenycidines and/or gramicidin s, or derivatives, analogues or modifications thereof.
Stellenbosch University
01/29/15
20150028825

Control circuit, control method, dc-dc converter and electronic device


A control circuit (115), a control method, a dc-dc converter and an electronic device are provided. The control circuit (115) is used to control the dc-dc converter to switch its operation modes.
St-ericsson Sa
01/22/15
20150025257

Docosahexaenoyl ethanolamides


The invention describes novel mono or dihydroxy docosahexaenoic acid (dha) analogues, their preparation, isolation, identification, purification and uses thereof.. .
The Brigham And Women's Hospital, Inc.
01/22/15
20150025255

Process for preparing synthetic prostacyclins


The presently disclosed subject matter provides methods of preparing synthetic prostacyclin analogues, including beraprost, either as racemic mixtures or as single stereoisomers. Also provided are novel synthetic intermediates for use in these methods..
Lung Biotechnology Inc.
01/22/15
20150025113

Rodenticidal norbormide analogues


The present invention relates to norbormide analogues having rodenticidal activity; rodenticidal compositions comprising the analogues; uses of the analogues as rodenticides; uses of the analogues in the manufacture of rodenticidal compositions; and methods for controlling rodents using the compositions.. .
Landcare Research New Zealand Limited
01/22/15
20150025002

Peptides and peptide derivatives based on xenin


The invention relates to peptides and peptide derivatives based on the naturally occurring peptide xenin. The invention provides a peptide of seq id no.
University Of Ulster
01/22/15
20150024463

Modified polymerases for improved incorporation of nucleotide analogues


The invention relates to modified polymerase enzymes which exhibit improved incorporation of nucleotide analogues bearing substituents at the 3′ position of the sugar moiety that are larger in size than the naturally occurring 3′ hydroxyl group. Also described are methods of using the polymerases to incorporate nucleotides into polynucleotides, particularly in the context of dna sequencing..
Illumina Cambridge Limited
01/22/15
20150022529

Recording device


The disclosure relates to a recording device for visualizing measured values and parameters of field devices in automation devices, having at least one analogue input for directly connecting at least one wired field device and having an ethernet interface for communicating with a superordinate device. A graphical display is provided for indications and an exchangeable storage unit is provided for retrospectively recording measured values and parameters of field devices.
Abb Technology Ag
01/22/15
20150022388

Device for converting analogue signals into digital signals


Method and device for converting analogue signals, of a plurality of pathways, into digital signals. A common circuit (2, 3) generates first analogue signals corresponding to high-order bits of digital signals for each pathway, a first means compares the first analogue signals with the signal to be converted.
Centre National De La Recherche Scientifique (cnrs
01/15/15
20150018518

Ghrelin analogues


The present invention relates, inter alia, to ghrelin analogues and their medical use, for example in the treatment of cachexia, chronic obstructive pulmonary disease, gastrointestinal disorders (e.g., gastroparesis and/or inflammatory disorders such as colitis, gut barrier dysfunction, and ischemia reperfusion injury), loss of body weight, and decreased appetite.. .
Zealand Pharma A/s
01/15/15
20150017955

Telecommunication system and method that can be used to establish telecommunications with the use of a vehicle using the registration plate code


Communication system and method which makes it possible to establish telecommunications with the vehicle user by means of its number plate code, making it possible to establish telecommunications with the vehicle owner by means of their public number and unique identification, thereby linking them to a communication means of their choice (a mobile telephone number, e-mail, web profile or personal analogue communication means), which is hidden from third parties as well as to certain pre-established communication functions (functionality codes), which respond to concrete needs of the users.. .
Person To Vehicle S.l
01/15/15
20150017238

Methods and compositions for treating diabetes


Described herein are methods and compositions for treating diabetes mellitus, concerning oral pharmaceutical compositions comprising insulin in combination with a glp-1 analogue.. .
Oramed, Ltd.
01/15/15
20150017203

Combination product for treating excess weight and/or for improving the figure


A combination product includes as active substances, at least an inhibitor of the hmg-coa-reductase enzyme and citrulline, or a bioequivalent compound thereof, for treating excess weight or obesity and/or the accumulation of body fat. A cosmetic treatment method for improving or slimming the figure and/or for stimulating the loss of excess weight and/or of cellulite and/or for limiting the accumulation thereof, includes the administration of a combination product including as active substances, at least an inhibitor of the hmg-coa-reductase enzyme or a physiologically acceptable salt thereof, and citrulline, or a bioequivalent compound thereof, or one of theirs analogues, and the renewal of the administration until the expected cosmetic effect is obtained.
Institut National De La Recherche Agronomique - Inra
01/15/15
20150017201

Novel nicotine dna vaccines


The present invention provides dna-nanostructures comprising and at least one targeting moiety, wherein the at least one targeting moiety is linked to the dna-nanostructure; and wherein the at least one targeting moiety is nicotine or a nicotine analogue. These compounds elicit an immunogenic response in individuals and are useful as vaccines for ameliorating nicotine dependence..
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Ariz
01/15/15
20150017148

Netrin loop peptide mimetics and uses thereof


In certain embodiments compositions are provided that comprise a pentapeptide comprising the formula: c1-x2-x3-x4-c5 where c1 and c5 are independently selected cysteines or cysteine analogues, or other amino acids with sidechains suitable for cyclization, where the cysteines or cysteine analogs are attached to each other by a linkage that does not comprise x2, x3, and x4; where x2, x3, and x4 are independently selected amino acids; and the peptide, when administered to a cell alters app signaling and/or switches app processing from aberrant to normal. The compositions mitigate amyloid plaque formation..
Buck Institute For Research On Aging
01/08/15
20150011781

Cu-mediated annulation for the production of 1-amino-2-naphthalenecarboxylic acid derivatives


Invention provides a cheaper and practical protocol for the construction of a wide variety of 1-amino-2-naphthalene-carboxylic acid derivatives and their structural analogues that proceeds with high yields in a single step via intramolecular cascade cyano ene reaction.. .
Council Of Scientific & Industrial Research
01/08/15
20150011773

Radiolabeled amino acids for diagnostic imaging


This invention relates to novel compounds suitable for labeling by 18f and to the corresponding 18f labeled compounds themselves, 19f-fluorinated analogues thereof and their use as reference standards, methods of preparing such compounds, compositions comprising such compounds, kits comprising such compounds or compositions and uses of such compounds, compositions or kits for diagnostic imaging by positron emission tomography (pet).. .
Piramal Imaging Sa
01/08/15
20150011637

Crystal form of prostaglandin analogue, and preparation method and use thereof


Provided are a crystal form b of a compound having the structure as represented by formula i, and preparation method and use thereof. The x-ray powder diffraction (xrpd) chart of the crystal form b has characteristic peaks at the following diffraction angles: 2.9±0.2°, 6.5±0.2°, 12.6±0.2°, 13.1±0.2° and 20.6±0.2°..
Shanghai Techwell Biopharmaceutical Co., Ltd
01/08/15
20150011621

Formylated xanthocillin analogues as neuroprotective agents


Formylated xanthocillin analogs can be used in the treatment of neurodegenerative diseases. The analogs can be prepared synthetically, and at least some of the analogs can be obtained from a microorganism strain of the penicillium chrysogenum species..
Neuron Biopharma, S.a.
01/08/15
20150011603

Etomidate analogues that do not inhibit adrenocortical steroid synthesis


The invention is directed to compounds according to formula (i): where r1 is l1c(o)ot or l1c(o)ol2c(o)ot; r2 is a substituted or unsubstituted c1-c10 alkyl, c2-c10 alkenyl, or c2-c10 alkynyl, or r1; n is an integer from 0 to 5; each r3 is independently halogen or r2; r4 and r5 are independently h, halogen, cn or cf3; l1 and l2 are each independently a bond, a substituted or unsubstituted c1-c10 alkylene, c2-c10 alkenylene, or c2-c10 alkynylene; and t is h, a substituted or unsubstituted c1-c10 alkyl, c2-c10 alkenyl, or c2-c10 alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (i) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition..
The Brigham And Women's Hospital, Inc.
01/08/15
20150011494

Therapeutic curcumin derivatives


Curcumin analogues and methods are provided for treatment of disease.. .
Stc.unm
01/08/15
20150011467

Oxyntomodulin analogues and their effects on feeding behaviour


Compounds of the invention are novel peptide analogues of oxyntomodulin (oxm) in which one or more amino acids of the oxm sequence have been changed. Changing amino acids 15-24 of oxm to either amino acids 968-977 of the α-latrotoxin peptide (and variations thereof) or amino acids 15-24 of exendin-4 (and variations thereof), or combinations of sequences from these sources, and/or changing amino acids 27-33 of oxm to amino acids 27-33 of exendin-4, and/or the addition of amino acids to the c-terminus of the peptide, results in a series of analogues of oxm that demonstrate the oxm like activity of reducing food intake, and with certain embodiments a greater ability to decrease food intake..
Imperial Innovations Limited
01/08/15
20150011462

Derivatives of glp-1 like peptides, and uses thereof


The invention relates to derivatives of glp-1 like peptides which are c-terminally extended analogues of native glp-1. The derivatives comprise two side chains, one at a position corresponding to position 42, and one at a position corresponding to position 18, 23, 27, 31, 36, or 38, wherein both positions are when compared to glp-1(7-37).
Novo Nordisk A/s
01/08/15
20150010569

Inhibitors of complement activation


The invention relates to factor d inhibitors, which bind to factor d and block the functional activity of factor d in complement activation. The inhibitors include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like fab, f(ab′)2 and fv, small molecules, including peptides, oligonucleotides, peptidomimetics and organic compounds.
Genentech, Inc.
01/08/15
20150010531

Compounds and methods for the treatment of vascular disease


The present invention relates to a method for the treatment of vascular dysfunction, reducing ischemic pain and/or treatment of a vascular disease comprising administering a therapeutically effective amount of annexin a5 or a functional analogue or variant thereof to a patient in need of such treatment. The vascular dysfunction, ischemic pain and/or vascular disease may be associated with impaired endothelium mediated vasodilatation, a reduced enos activity, and/or a reduced no bioavailability.
Annexin Pharmaceuticals Ab
01/08/15
20150010469

Bisphenol ether compounds with novel bridging groups and methods for their use


Or a pharmaceutically acceptable salt, tautomer, stereoisomer or deuterated analogue thereof, wherein x, r, r1, r2, r3, r4, m1, m2, l1, l2, j1, j2, a1, a2, b1 and b2 are as defined herein, are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided..
01/08/15
20150009511

Monitoring device, the monitoring of an area of building or land, using at least one light waveguide


A monitoring device is provided that is used for the monitoring of an area of building or land, including an optical strand used as a sensor, one optical source for emitting an optical emission signal transmitted in the optical strand, and one optical analogue detector for detecting an intensity of an optical return signal corresponding to the optical emission signal returning from the optical strand. The monitoring device is arranged as a compact unit and includes a controller for alternately activating and deactivating the emission of the optical source so that a ratio between the non-emission duration and the emission duration is greater than 5000.
01/01/15
20150005585

Biopotential signal acquisition system and method


A biopotential signal acquisition system, comprising: a first active electrode including an integrated pre-amplifier and an analogue to digital converter; a second active electrode including an integrated pre-amplifier and an analogue to digital converter, wherein the second active electrode has variable gain; a test signal generator for generating a test signal at a test frequency and coupling the test signal to the first and/or second active electrodes; and a digital signal processor configured to: process the digital outputs of the first and second active electrodes to derive a gain control signal based on a difference between the first and second active electrode outputs at the test frequency, and apply the gain control signal to the second active electrode. The disclosure also relates to an electronic circuit or device and a biopotential signal acquisition method..
Stichting Imec Nederland
01/01/15
20150005384

Crystal form of prostaglandin analogue, and preparation method and use thereof


Provided are a crystal form a of a compound having the structure as represented by formula i, and preparation method and use thereof. The x-ray powder diffraction (xrpd) chart of the crystal form a has characteristic peaks at the following diffraction angles: 2.9±0.2°, 13.6±0.2°, 17.3±0.2° and 18.6±0.2°..
Shanghai Techwell Biopharmaceutical Co., Ltd.
01/01/15
20150005274

Use of squalamine or analogue as a disinfecting agent


The present invention also provides an aqueous or water-soluble disinfecting composition beneficial for a use according to the invention, characterized in that as disinfecting active compound it comprises a said antibacterial and antifungal compound selected from squalamine and a said squalamine-analogue aminosteroid compound and suitable excipients for a water-soluble or aqueous formulation.. .
01/01/15
20150005238

Treatment of coagulopathy with hyperfibrinolysis


The present invention relates to the use of thrombomodulin analogues for the manufacture of a medicament for the treatment of coagulopathy with hyperfibrinolysis, such as haemophilia disorders. These thrombomodulin analogues exhibit at therapeutically effective dosages an antifibrinolytic effect.
Paion Deutschland Gmbh
01/01/15
20150005231

Halogen-stabilized insulin


An insulin analogue comprises a b-chain polypeptide incorporating a halogenated phenylalanine at position b24, b25 or b26. The halogenated phenylalanine may be ortho-monofluoro-phenylalanine, ortho-monobromo-phenylalanine, ortho-monochloro-phenylalanine, or para-monochloro-phenylalanine.
Case Western Reserve University
01/01/15
20150005169

Preparation method, agricultural composition and applications of natural brassinolide analogs


The present invention provides extraction methods and uses of brassinolide analogues extracted from a plant, including the uses for the promotion of growth, resistance to low temperature and salt tolerance of a plant. Furthermore, the present invention also provides agricultural compositions comprising the brassinolide analogues..
Chengdu Newsun Cropscience Co., Ltd
01/01/15
20150004210

Sustained release formulations comprising gnrh analogues


The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogues thereof and the manufacturing process of such pharmaceutical compositions..
Ipsen Pharma S.a.s
01/01/15
20150004173

Compositions and methods for analyzing histidine phosphorylation


A peptide is disclosed of the general structure: z—w—y, wherein z and y are independently a one to eight amino acid sequence wherein the amino acids are selected from glycine and alanine and w is a non-hydrolyzable phis analogue. Such peptides can be used to produce sequence-independent anti-phosphohistidine antibodies.
Sanofi
12/25/14
20140378408

Nucleoside 5'-phosphorothioate analogues and uses thereof


Particular nucleoside 5′-phosphorothioate analogues, such as, adenosine or uridine 5′-di- or tri-phosphorothioate analogues in which at least one of the bridging oxygen atoms of the phosphorothioate is replaced by a group such as —ch2— or —ccl2—, and at least one of the non-bridging atoms or negatively-charged atoms of the phosphorothioate is either a sulfur atom or a sulfur ion can be formulated into pharmaceutical compositions. These compounds are useful for treatment of osteoarthritis/calcium pyrophosphate dihydrate (cppd) deposition disease..
The Medical Research, Infrastructure, And Health Services Fund Of The Tel-aviv Medical Center
12/25/14
20140377743

Chemically cleavable 3'-o-allyl-dntp-allyl-fluorophore fluorescent nucleotide analogues and related methods


This invention provides a nucleotide analogue comprising (i) a base selected from the group consisting of adenine, guanine, cytosine, thymine and uracil, (ii) a deoxyribose, (iii) an allyl moiety bound to the 3′-oxygen of the deoxyribose and (iv) a fluorophore bound to the base via an allyl linker, and methods of nucleic acid sequencing employing the nucleotide analogue.. .
The Trustees Of Columbia University In The City Of New York
12/25/14
20140377171

Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof


The invention relates to a method of imaging pancreatic β-cells, endocrine gastroenteropancreatic tumors and bronchial and thyroid neuroendocrine tumors and a method of treating endocrine gastroenteropancreatic tumors and bronchial and thyroid neuroendocrine tumors by targeting of glucose-independent insulinotropic polypeptide receptors (gip receptors). Compounds considered are gip or a gip analog, each carrying a radionuclide, optionally complexed through a chelator.
12/18/14
20140371456

Enzymatic transamination of cyclopamine analogs


Provided are processes for the synthesis of amino analogues from ketone starting materials.. .
12/18/14
20140371193

Organometallic complexes as therapeutic agents


This invention comprises salophene-based metallic complexes. Included are metal-chelating analogues, and method of their preparation and use.
Women & Infants' Hospital
12/18/14
20140370082

Cyclosporine analogue mixtures and their use as immunomodulating agents


The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine a. The mixtures possess enhanced efficacy and reduced toxicity over the individual isomers and over naturally occurring and other presently known cyclosporines and cyclosporine derivatives.
Aurinia Pharmaceuticals Inc.
12/18/14
20140369624

Flow imaging


A system suitable for reducing static or slow moving echoes from acoustic boundaries in a system such as pipe walls, blood vessels, tissue structures so that an image from flowing or time varying media such as water, oil, blood etc may be imaged more clearly, the system including an analogue-to-digital converter for digitizing a received analogue signal from a detector, means for digitally separating static or slow moving components of the digital signal, a digital-to-analogue converter to provide an analogue version of the separated static or slow moving components of the signal, and a subtractor to subtract the analogue version of the static or the slow moving components of the signal from an analogue signal received from a detector to produce an analogue signal corresponding to the remaining flow components of the signal.. .
General Electric Company
12/18/14
20140368368

Continuous-time mash sigma-delta analogue to digital conversion


Continuous-time mash sigma-delta adc with a first modulator with 1.5 bit and a second modulator with 1 bit each receiving also the feedback from the other modulator. Sampling is at higher rate at the second modulator and decimation is performed before summing its output to the output of the first modulator..
St-ericsson Sa
12/11/14
20140364836

Pharmaceutical compositions for the treatment of inner ear disorders


The present invention provides compositions containing (i) a pharmaceutically active agent selected from a group consisting of an arylcycloalkyamine of a derivative, analogue or pharmaceutically active salt thereof, and (ii) a biocompatible polymer or a combination of biocompatible polymers. The compositions or medicaments containing these compositions may be used for the prevention and/or treatment of inner ear diseases, e.g.


Popular terms: [SEARCH]

Analogue topics: Carbon Dioxide, Amino Acid, Radio Signal, Inorganic Compounds, Hydrogen Production From Water, Electrolysis, Semiconductor, High Energy, Semiconductor Material, Transmitter, Synchronization, Concurrent, Surfactant, Hyperglycemia, Pharmaceutically Acceptable Salt

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Analogue for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Analogue with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         









0.9075

3163

458996 - 0 - 71